Teva Pharmaceutical Industries Limited (TEVA) is a publicly traded Healthcare sector company. As of November 17, 2026, TEVA trades at $42.17 with a market cap of $51.92B and a P/E ratio of 66.68. TEVA moved -0.95% today. Year to date, TEVA is +37.59%; over the trailing twelve months it is +67.59%. Its 52-week range spans $12.47 to $44.78. Analyst consensus is strong buy with an average price target of $51.57. Rallies surfaces TEVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TEVA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $42.17 |
| Market Cap | $51.92B |
| P/E Ratio | 66.68 |
| EPS | $0.62 |
| Dividend Yield | 0.09% |
| 52-Week High | $44.78 |
| 52-Week Low | $12.47 |
| Volume | 14.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.10B |
| Net Income | $709.00M |
| Gross Margin | 64.41% |
11 analysts cover TEVA: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $51.57.